stars 1 stars 2 stars 3

Biological Control, Evolved. Evolution Biotechnologies is working to expand biological control from its successful application within agriculture, bringing this to the control of medically important targets. Biological control is an environmentally friendly approach using natural agents. These are highly specific, reducing any side effects. They are applied in small doses and spread naturally, producing long-lasting and sustainable effects. Initial targets include: - The house dust mite, the major cause of asthma - The bedbug, a resurgent infestation - Pseudomonas aeruginosa, a bacterial infection that is highly resistant to existing antibiotics Operating from its bases in the United Kingdom and United States of America, the company is addressing worldwide issues with projected markets exceeding £1 billion per annum

Evolution Biotechnologies Questions

The Evolution Biotechnologies annual revenue was $4 million in 2026.

The NAICS codes for Evolution Biotechnologies are [54171, 541713, 5417, 54, 541].

The SIC codes for Evolution Biotechnologies are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users